AR101588A1 - Compuesto tetrahidroimidazo[1,5-d][1,4]oxazepínico - Google Patents
Compuesto tetrahidroimidazo[1,5-d][1,4]oxazepínicoInfo
- Publication number
- AR101588A1 AR101588A1 ARP150102665A ARP150102665A AR101588A1 AR 101588 A1 AR101588 A1 AR 101588A1 AR P150102665 A ARP150102665 A AR P150102665A AR P150102665 A ARP150102665 A AR P150102665A AR 101588 A1 AR101588 A1 AR 101588A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- oxazepinic
- tetrahydroimidazo
- compound
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicación 1: Un compuesto representado por la fórmula (1) caracterizado porque R es un grupo metilo o un grupo fluorometilo; R¹ es un átomo de flúor, un grupo metoxi, un grupo etoxi, un grupo fluorometiloxi, un grupo difluorometiloxi o un grupo oxetan3-iloxi; R² es un átomo de hidrógeno o un átomo de flúor; R³ es un átomo de hidrógeno; R⁴ es un grupo metilo, un grupo etilo, un grupo isopropilo, un grupo tert-butilo, un grupo ciclopropilo, un grupo ciclobutilo o un grupo 1-metilciclobutilo; o una sal farmacéuticamente aceptable de esta.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014169189A JP2017206438A (ja) | 2014-08-22 | 2014-08-22 | テトラヒドロイミダゾ［１，５−ｄ］［１，４］オキサゼピン化合物（ＴＥＴＲＡＨＹＤＲＯＩＭＩＤＡＺＯ［１，５−ｄ］［１，４］ＯＸＡＺＥＰＩＮＥＣＯＭＰＯＵＮＤ） |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR101588A1 true AR101588A1 (es) | 2016-12-28 |
Family
ID=55347724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102665A AR101588A1 (es) | 2014-08-22 | 2015-08-19 | Compuesto tetrahidroimidazo[1,5-d][1,4]oxazepínico |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20160052937A1 (es) |
| JP (1) | JP2017206438A (es) |
| AR (1) | AR101588A1 (es) |
| TW (1) | TW201609750A (es) |
| WO (1) | WO2016027844A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021035911A (ja) * | 2017-11-15 | 2021-03-04 | 大日本住友製薬株式会社 | 縮環ピラゾール誘導体及びその医薬用途 |
| JP7242548B2 (ja) | 2017-11-24 | 2023-03-20 | 住友ファーマ株式会社 | ６，７－ジヒドロピラゾロ［１，５－ａ］ピラジノン誘導体及びその医薬用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6949542B2 (en) * | 2002-02-06 | 2005-09-27 | Hoffman-La Roche Inc. | Dihydro-benzo[b][1,4]diazepin-2-one derivatives |
| WO2010068520A2 (en) * | 2008-12-11 | 2010-06-17 | Cara Therapeutics, Inc. | Substituted imidazoheterocycle derivatives |
| EP2666775A1 (en) * | 2012-05-21 | 2013-11-27 | Domain Therapeutics | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors |
| CA2901168C (en) * | 2013-02-28 | 2020-09-22 | Eisai R&D Management Co., Ltd. | Tetrahydroimidazo[1,5-d][1,4]oxazepine derivative |
-
2014
- 2014-08-22 JP JP2014169189A patent/JP2017206438A/ja active Pending
-
2015
- 2015-08-19 AR ARP150102665A patent/AR101588A1/es unknown
- 2015-08-20 US US14/830,970 patent/US20160052937A1/en not_active Abandoned
- 2015-08-20 WO PCT/JP2015/073299 patent/WO2016027844A1/ja active Application Filing
- 2015-08-20 TW TW104127202A patent/TW201609750A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201609750A (zh) | 2016-03-16 |
| WO2016027844A1 (ja) | 2016-02-25 |
| US20160052937A1 (en) | 2016-02-25 |
| JP2017206438A (ja) | 2017-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR105238A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
| MA39749A (fr) | Dérivés de pipéridine-dione | |
| PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
| PH12016501007A1 (en) | Substituted benzamides and methods of use thereof | |
| MX2015012629A (es) | Compuestos de imidazo piridina. | |
| AR095039A1 (es) | Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico | |
| PH12015502232A1 (en) | Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | |
| EA201591098A1 (ru) | Бициклические пиримидиновые соединения | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| WO2014144545A3 (en) | Substituted benzoxazoles and methods of use thereof | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| RS54730B1 (sr) | Inhibitori beta sekretaze | |
| AR088691A1 (es) | Derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo | |
| PH12015501588A1 (en) | Compounds and methods for treating bacterial infections | |
| AU2015352440B2 (en) | Compounds | |
| AR095523A1 (es) | Derivados piridin-4-ilo | |
| BR112016027691A2 (pt) | Composto de tetra-hidropiridopirimidina e seus usos | |
| AR101036A1 (es) | Amidas de benzoxazinona como reguladores del receptor mineralocorticoide | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| RU2014103098A (ru) | Противозудный агент | |
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| AR101588A1 (es) | Compuesto tetrahidroimidazo[1,5-d][1,4]oxazepínico | |
| AR104241A1 (es) | Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos | |
| ES2722074T3 (es) | Nuevos polimorfos | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |